Back to the main directory
Company Analysis / Equity
- DELTA PLUS - Turnover 2018 (=) Q4 In line, prospects remain strong. by MidCap Partners
- AST GROUPE - Turnover 2018 (-) A very complicated year. by MidCap Partners
- CA 2018: 6,1 M€, +56,5% et +29,3 à pc, en ligne - Opinion : Achat - Objectif : 8,07 € vs 7,85 € - Potentiel +50,8% by GreenSome Finance
- FRANCAISE DE L'ENERGIE - Under good auspices (+) by MidCap Partners
- Magellan's Momentum Keeps On Building by Morningstar
- Iress No Longer Overvalued Following Technology Sector Sell-Off by Morningstar
- BRD - A Bunch Of Exceptional Numbers by Concorde Securities
- Morningstar | Competition not Getting any Easier for SingTel; FVE Increased to SGD 2.80. See Updated Analyst Note from 14 Feb 2019 by Morningstar
- ASTRAZENECA: Behind tax one-offs, a solid underlying growth | NEUTRAL | 5850p by Bryan Garnier
- BIC adapts to the digital and fast-changing environment | NEUTRAL | EUR92 by Bryan Garnier
- IMERYS: Bold move on the talc but environment remains challenging | NEUTRAL | EUR65 by Bryan Garnier
- DBV TECHNOLOGIES: Building-up a newsflow until BLA resubmission expected in Q3 19 | BUY | EUR46 by Bryan Garnier
- THERANEXUS - Cash position end 2018 (+) Projects that still require little cash. by MidCap Partners
- PLASTIC OMNIUM - Net Income 2018 (=) Good resistance. by MidCap Partners
- LECTRA - Some uncertainties (=) by MidCap Partners
- ASX 1H Result in Line With Expectations but Interest Income Surprisingly Strong by Morningstar
- Goodman Loosens Development Throttle on Surging Demand. FVE up 10% to AUD 11.20 by Morningstar
- Healthscope’s 1H Result Overshadowed by Brookfield Takeover Offer by Morningstar
- Morningstar | European Expansion Continues to Deliver Strong Results for Breville by Morningstar
- Morningstar | Magellan Expertly Navigating Wild Seas With Another Strong Half. AUD 29 FVE Unchanged by Morningstar
- Morningstar | Cheers to Treasury Wine’s Solid 1H, but Valuation Runneth Over by Morningstar
- InMed Pharmaceuticals - Entering the clinic by the end of the year by Edison Investment Research
- Morningstar | Best Idea Update: Decent 2018 Close and Prospects for NN by Morningstar
- Morningstar | KBC Reports 2018 Results in Line With Expectations; FVE Maintained by Morningstar
- Unicharm's Products Benefit From Rising Demand and Premiumization by Morningstar